Article info
PostScript
Letter
Vonoprazan Helicobacter pylori eradication therapy: ethical and interpretation issues
- Correspondence to Dr David Y Graham, Department of Medicine, Baylor College of Medicine and Michael E DeBakey Veterans Affairs Medical Center, RM 3A-318B (111D), 2002 Holcombe Boulevard, Houston, TX 77030, USA; dgraham{at}bcm.edu
Citation
Vonoprazan Helicobacter pylori eradication therapy: ethical and interpretation issues
Publication history
- Received March 4, 2016
- Revised March 14, 2016
- Accepted March 21, 2016
- First published April 7, 2016.
Online issue publication
January 06, 2017
Article Versions
- Previous version (7 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/